Register

Macular Degeneration Information

Learn about this condition, its impact, and our breakthrough treatment approach

Begin Assessment

WHAT IS MACULAR DEGENERATION

Age-related macular degeneration (AMD) is a progressive eye condition that affects the macula, the central part of the retina responsible for sharp, central vision. The macula allows us to see fine details clearly and is essential for activities like reading, driving, and recognizing faces.

As AMD progresses, it can lead to a gradual or sudden loss of central vision, while peripheral (side) vision typically remains intact. It is a leading cause of severe vision loss and legal blindness in people over the age of 60 in developed countries.

While macular degeneration does not result in complete blindness, the loss of central vision can significantly impact quality of life and independence.

TYPES OF MACULAR DEGENERATION

There are two main types of age-related macular degeneration:

  • Dry AMD (Non-neovascular): This is the most common form, accounting for approximately 85-90% of cases. Dry AMD develops slowly as the light-sensitive cells in the macula gradually break down. Yellow deposits called drusen accumulate beneath the retina, leading to a thinning and drying out of the macula. Vision loss with dry AMD is usually gradual.
  • Wet AMD (Neovascular): This less common form (10-15% of cases) is more severe and can cause rapid vision loss. In wet AMD, abnormal blood vessels grow under the retina and macula. These vessels can leak blood and fluid, leading to scarring and rapid damage to the macula.

AMD is also classified by stages:

  • Early AMD: Usually no symptoms; medium-sized drusen may be present.
  • Intermediate AMD: Some vision loss may occur; larger drusen and/or pigment changes in the retina.
  • Late AMD: Noticeable vision loss from either geographic atrophy (advanced dry AMD) or neovascular AMD (wet AMD).

SYMPTOMS

Symptoms of macular degeneration may include:

  • Blurriness or distortion in the center of vision
  • A dark or empty area in the center of vision
  • Difficulty reading without bright light
  • Decreased brightness or intensity of colors
  • Difficulty recognizing faces
  • Straight lines appearing wavy or distorted (especially in wet AMD)
  • Objects appearing smaller or farther away than they actually are
  • Difficulty adapting to low light levels

It's important to note that early AMD may not cause any noticeable symptoms. Regular eye examinations are crucial for early detection, especially for those at higher risk.

RISK FACTORS

  • Age: The risk increases significantly with age, particularly after 50.
  • Genetics/Family History: Having a family member with AMD increases your risk.
  • Race: Caucasians are at higher risk than other races.
  • Smoking: Smoking doubles the risk of AMD.
  • Obesity: Being overweight increases the risk of developing advanced AMD.
  • Cardiovascular Disease: AMD is associated with heart and blood vessel diseases.
  • High Blood Pressure: Hypertension may increase the risk.
  • High Cholesterol: Elevated cholesterol levels may contribute to AMD.
  • Sun Exposure: Prolonged exposure to UV light may increase risk.
  • Diet: Low intake of antioxidants, zinc, and omega-3 fatty acids may increase risk.

DIAGNOSIS

Diagnosis of macular degeneration typically involves:

  • Comprehensive Eye Exam: Including visual acuity test, dilated eye exam, and examination of the retina.
  • Amsler Grid Test: A simple test that can detect changes in central vision. Patients look at a grid pattern and note any distortion, blurriness, or blank spots.
  • Optical Coherence Tomography (OCT): Provides detailed cross-sectional images of the retina, allowing detection of drusen, fluid, and changes in retinal thickness.
  • Fluorescein Angiography: A dye is injected into the arm and photographs are taken as the dye passes through the blood vessels in the eye, revealing any leaking vessels (especially for wet AMD).
  • Indocyanine Green Angiography: Similar to fluorescein angiography but uses a different dye that can better image the deeper retinal vessels.
  • Fundus Autofluorescence: Images that show the health of the retinal pigment epithelium (RPE), the layer beneath the retina.

STANDARD TREATMENT

Dry AMD Treatment:

  • Nutritional Supplements: The Age-Related Eye Disease Study (AREDS and AREDS2) formulations - specific combinations of vitamins C and E, zinc, copper, lutein, and zeaxanthin may slow progression in intermediate and advanced cases.
  • Lifestyle Modifications: Quitting smoking, maintaining a healthy diet rich in green leafy vegetables and fish, exercising regularly, and maintaining normal blood pressure and cholesterol levels.
  • Low Vision Aids: Magnifying devices, special lenses, large-print materials, and electronic reading aids.

Wet AMD Treatment:

  • Anti-VEGF Therapy: Injections of drugs that block vascular endothelial growth factor (VEGF), which stimulates abnormal blood vessel growth. Commonly used medications include bevacizumab (Avastin), ranibizumab (Lucentis), and aflibercept (Eylea). These can help stop leakage and in some cases improve vision.
  • Photodynamic Therapy (PDT): A combination of a light-sensitive drug and a special laser to damage the abnormal blood vessels.
  • Laser Photocoagulation: Less commonly used now, this treatment uses a high-energy laser beam to destroy abnormal blood vessels.

Currently, there is no treatment to restore vision that has been lost due to advanced AMD. However, research is ongoing, including stem cell therapy, gene therapy, and new drug development.

OUR APPROACH

Our approach to macular degeneration focuses on a comprehensive, personalized treatment plan that aims to slow disease progression, preserve existing vision, and enhance overall eye health. We integrate advanced therapies with nutritional and lifestyle interventions to target the root causes of macular degeneration.

Our protocol includes:

  • Specialized nutritional supplementation beyond standard AREDS2 formulations
  • Microcirculation enhancement therapies to improve blood flow to the macula
  • Antioxidant and anti-inflammatory protocols
  • Lifestyle modification guidance specific to retinal health
  • Advanced monitoring to detect early changes and adjust treatment accordingly

Our goal is to not only manage the condition but to create a comprehensive approach that addresses the underlying factors contributing to macular degeneration while supporting the body's natural healing processes.

Begin Assessment Process

REFERENCES

  • American Academy of Ophthalmology. "Age-Related Macular Degeneration." (2023)
  • National Eye Institute. "Age-Related Macular Degeneration." (2021)
  • The Lancet. "Age-related macular degeneration." (2018)
  • American Journal of Ophthalmology. "Current and emerging therapies for age-related macular degeneration." (2022)